AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Set up an RSS feed
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Pozen record 0-2 in migraine but third drug is 'good shot'.
June 7, 2004... Casting a dark cloud over Memorial Day weekend for Pozen Inc. was word the Friday before from the FDA that its second migraine drug is not approvable. But Wall Street's thunder was not heard until Tuesday, when Pozen disclosed the news and saw...
10 biggest U.S. gainers for the week.
June 7, 2004...
10 BIGGEST U.S. GAINERS FOR THE WEEK
(By Percent) (By Dollars)
Allos 43.01 CV Therapeutics 3.58
Dyax 31.57 Dyax 3.11
CV Therapeutics 27.37 Gen-Probe ...
10 biggest U.S. losers for the week.
June 7, 2004...
10 BIGGEST U.S. LOSERS FOR THE WEEK
(By Percent) (By Dollars)
Miravant -35.15 OSI Pharma -3.87
Northwest BioThera -25.00 Onyx Pharma -3.83
CombiMatrix -17.86 ...
Public financing of biotechnology: May 2004.
June 7, 2004...
Public Financing Of Biotechnology: May 2004
I. COMMENCED TRADING IN APRIL
Company Date Date Shares/ Price Shares
(Symbol) # Filed Comm. Units (M) Out
...
Other financings of public biotechnology companies: May 2004.
June 7, 2004...
Other Financings Of Public Biotechnology Companies:
May 2004
TOTAL: $1,030.39M
Company Type Of Number Of Amount
(Symbol) # Financing Shares, Units Raised
...
Venture capital and corporate investments in biotechnology companies: May 2004.
June 7, 2004...
Venture Capital And Corporate Investments In Biotechnology
Companies: May 2004
I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $501.49M
Company Location Date
Acologix Inc. Emeryville, Calif. ...
Money raised by Biotech in 2004: January-May.
June 7, 2004...
Money Raised By Biotech In 2004:
January-May
Type of Jan. ($M) Feb. ($M)
financing
Public offerings 352.1 997.8
Private biotechs 444.3 ...
BioWorld stock report for public biotechnology companies.
June 7, 2004...
BioWorld Stock Report For Public Biotechnology Companies
Company Symbol Close Close
5/28 6/4
Aastrom Biosci ASTM 0.85 0.97...
In-licensing strategy perilous; Phase II drugs not safe, either.(Panel's Warning At BIO 2004)
June 14, 2004... SAN FRANCISCO -- "There is a saying in the gambling world that, at every poker table there is a fool, and if you don't know who the fool is, you're the fool," said Stelios Papadopoulos, vice chairman of SG Cowen Securities Corp., during a panel...
10 biggest U.S. gainers for the week.
June 14, 2004...
10 BIGGEST U.S. GAINERS FOR THE WEEK
(By Percent) (By Dollars)
Avax Technol 29.63 ImClone Sys 5.27
StemCells 21.71 Sepracor 1.76
LION bioscience ...
10 biggest U.S. losers for the week.
June 14, 2004...
10 BIGGEST U.S. LOSERS FOR THE WEEK
(By Percent) (By Dollars)
Ariad Pharma -34.00 OSI Pharma -11.01
AEterna -29.73 Genentech -7.86
Introgen -24.85...
Clinical trials update: May 2004.
June 14, 2004...
Clinical Trials Update: May 2004
Company * Product Description
(Country;
Symbol)
AUTOIMMUNE
Abbott Humira Adalimumab; fully
Laboratories (FDA-approved) human...
Non-U.S. clinical trials, regulatory submissions, recommendations and approvals: May 2004.
June 14, 2004...
Non-U.S. Clinical Trials, Regulatory Submissions,
Recommendations And Approvals: May 2004
Company * Product Description
(Country;
Symbol)
AUTOIMMUNE
Amgen Inc. Enbrel Etanercept;...
FDA submissions, approvals and other actions: May 2004.
June 14, 2004...
FDA Submissions, Approvals, And Other Actions: May 2004
Company * Product Description
(Country;
Symbol)
AUTOIMMUNE
Biogen Idec Antegren Humanized monoclonal
Inc. (BIIB) and ...
BioWorld stock report for public biotechnology companies.
June 14, 2004...
BioWorld Stock Report For Public Biotechnology Companies
Company Symbol Close Close % Change
6/4 6/10 WK
astrom Biosci ASTM 0.97 1.02 ...
Two players in tricky HCV race gain cash as virus marches on.
June 21, 2004... One of the sneakier and more challenging diseases is the liver condition brought about by the dreaded hepatitis C virus, which chronically afflicts about 2.7 million people in the U.S.--each at risk of fibrosis, cirrhosis, liver cancer, liver...
10 biggest U.S. gainers for the week.
June 21, 2004...
10 BIGGEST U.S. GAINERS FOR THE WEEK
(By Percent) (By Dollars)
Valentis 29.66 Pharmion 7.23
Renovis 23.42 Eyetech 6.95
Pharmion 18.08 Atrix Labs 4.62
Aphton ...
10 biggest U.S. losers for the week.
June 21, 2004...
10 BIGGEST U.S. LOSERS FOR THE WEEK
(By Percent) (By Dollars)
Imcor -42.67 Martek Bio -3.21
Avax Technol -31.43 Neurocrine Biosci -2.70
Lynx Therapeutics -28.21 QLTPhotoTher ...
Biotech-big pharma collaborations: new agreements, April 22-June 16, 2004 (#).
June 21, 2004...
Biotech-Big Pharma Collaborations:
New Agreements, April 22 - June 16, 2004 (#)
Biotech Co. * Pharma Co. Type/Product Area
(Country; (Country)
Symbol)
Access Unnamed ...
Manufacturing, marketing and distribution agreements between biotech and pharmaceutical companies: April 22-June 16, 2004 (#).
June 21, 2004...
Manufacturing, Marketing And Distribution Agreements
Between Biotech And Pharmaceutical Companies:
April 22-June 16, 2004 #
Biotech Co. * Pharma Co. Product
(Country; (Country)
Symbol)
Aero ...
Biotech-big pharma collaborations: modified and terminated agreements, April 22-June 16, 2004 (#).
June 21, 2004...
Biotech-Big Pharma Collaborations: Modified And
Terminated Agreements, April 22-June 16, 2004 #
I. MODIFIED AGREEMENTS
Biotech Co. * Pharma Co. Change from original
(Country; (Country) agreement...
BioWorld stock report for public biotechnology companies.
June 21, 2004...
BioWorld Stock Report For Public Biotechnology Companies
Company Symbol Close Close % Change Vol
6/10 6/18 WK YTD (000)
Aastrom Biosci ASTM 1.02...
Tarceva 'blockbuster' may falter in second line, but there's hope.
June 28, 2004... It was deja vu all over again when Tarceva scored big at the meeting of the American Society of Clinical Oncology last month, putting Genentech Inc. and partners OSI Pharmaceuticals Inc. and Roche Holdings Inc. in the limelight--just as the...
10 biggest U.S. gainers for the week.
June 28, 2004...
10 BIGGEST U.S. GAINERS FOR THE WEEK
(By Percent) (By Dollars)
Cytogen 32.74 Invitrogen 5.71
Northfield Labs 25.13 Biogen IDEC 4.33
OraSure Tech 24.70 OSI Pharma ...
10 biggest U.S. losers for the week.
June 28, 2004...
10 BIGGEST U.S. LOSERS FOR THE WEEK
(By Percent) (By Dollars)
IntraBiotics -71.3 IntraBiotics -9.81
Titan Pharma -20.4 Eyetech -3.20
Cholestech -19.6 MGI Pharma -2.55...
Biotechnology Company deals with other biotechnology companies: collaborations, agreements, equity participation, April 29-June 23, 2004.
June 28, 2004...
Biotechnology Company Deals With Other Biotechnology Companies:
Collaborations, Agreements, Equity Participation,
April 29 - June 23, 2004
Company * Company * Type/Product Area
(Country; Symbol) (Country;...
Biotechnology Company deals with miscellaneous companies: collaborations, agreements, equity participation, April 29-June 23, 2004.
June 28, 2004...
Biotechnology Company Deals With Miscellaneous Companies:
Collaborations, Agreements, Equity Participation,
April 29 - June 23, 2004
Company *
(Country; Symbol) Company Type/Product Area
Epoch ...
Manufacturing, marketing and distribution agreements between biotech companies: April 29 - June 23, 2004.
June 28, 2004...
Manufacturing, Marketing And Distribution Agreements
Between Biotech Companies: April 29 - June 23, 2004
Company * Company *
(Country; (Country;
Symbol) Symbol) Product
Active...
Biotech--Biotech collaborations: modified and terminated agreements, April 29 - June 23, 2004.
June 28, 2004...
Biotech--Biotech Collaborations: Modified And Terminated
Agreements, April 29 - June 23, 2004
I. MODIFIED AGREEMENTS
Company * Company * Change from original
(Country; Symbol) (Country; Symbol) agreement
...
BioWorld stock report for public biotechnology companies.
June 28, 2004...
BioWorld Stock Report For Public Biotechnology Companies
Company Symbol Close Close % Change Vol
6/18 6/25 WK YTD (000)
Aastrom Biosci ASTM 0.94 ...